Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients
Miloš Marković, Nataša Petronijević, Milena Stašević, Ivana Stašević Karličić, Milica Velimirović, Tihomir Stojković, Slavica Ristić, Mina Stojković, Nataša Milić, Tatjana Nikolić · 2023
Read Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients by Miloš Marković, Nataša Petronijević, Milena Stašević, Ivana Stašević Karličić, Milica Velimirović, Tihomir Stojković, Slavica Ristić, Mina Stojković, Nataša Milić, Tatjana Nikolić (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10741951.txt.
Description
Miloš Marković and co-authors measure tryptophan breakdown products in schizophrenia blood in a 2023 study. The kynurenine pathway makes brain-active compounds tied to the illness. Blood levels may not mirror the brain, a caveat the team face head-on. Carefully matched patients and controls were sampled in flare and remission.
Both kynurenine and its acid product ran clearly lower in patients. The gap held across illness phase, drug type, and history. The pathway's overall ratio stayed normal, though. Lower levels may mark something subtler than pathway overdrive. The findings temper claims that blood readouts expose brain chemistry in schizophrenia.
Catalog record
| CREATOR | Miloš Marković, Nataša Petronijević, Milena Stašević, Ivana Stašević Karličić, Milica Velimirović, Tihomir Stojković, Slavica Ristić, Mina Stojković, Nataša Milić, Tatjana Nikolić |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |